Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Wall Street Opens Higher on Fiscal, Vaccine Hopes; Dow up 216 Pts

Published 12/14/2020, 09:36 AM
Updated 12/14/2020, 09:46 AM
© Reuters.
US500
-
DJI
-
ALXN
-
IXIC
-
AZN
-
SWI
-
ABNB
-
DASH
-

By Geoffrey Smith 

Investing.com -- U.S. stock markets opened higher on Monday on signs that plans for a fiscal stimulus package had been simplified to a degree that might let them pass Congress this week, while the start of distribution of the Pfizer/BioNTech vaccine provided a welcome reassurance against the backdrop of continued high numbers of deaths and hospitalizations from the coronavirus.

By 9:40 AM ET (1440 GMT), the Dow Jones Industrial Average was up 216 points, or 0.7%, at 30,262 points. The S&P 500 was up 0.8% and the Nasdaq Composite was outperforming with a gain of 1.0%.

Over the weekend, reports emerged that the bipartisan group of lawmakers behind the $908 billion stimulus proposal endorsed by House Democrats were prepared to split off contentious clauses about legal liability protections for businesses and aid for state and local governments, in the hope of getting the less controversial pieces of the package through before Friday, when the goverrment’s spending authority expires.

The development represents something of a victory for Senate Majority Leader Mitch McConnell, who has resisted any plans for his party sees as a bailout for profligate local government. House Democrats, for their part, have insisted that the $160 billion in aid foreseen is vital to help front-line services defeat the pandemic. The number of Americans in hospital with the disease rose to a new record high of over 109,000 at the weekend, while the number of deaths was also higher than the previous week.

This week will see the last Federal Reserve policy meeting of the year, and comes with a certain amount of speculation on further monetary easing already baked into prices. However, views are mixed, something that creates a two-way risk to price if the Fed over- or under-delivers.  

"A faithful and fulsome reading of the last FOMC and its meeting minutes, plus statements from some key FOMC members, suggest to us that – at least through the media blackout period which began on Friday December 4 – there is no committee consensus for long maturity purchases yet," said Bank of New York macro strategist John Velis in a research note to clients. 

Among early movers, DoorDash (NYSE:DASH) stock and Airbnb (NASDAQ:ABNB) stock both fell on profit-taking after their astonishing debuts last week provoked much commentary about bubbles over the weekend. Doordash fell 12.2% and AirBnB fell 9.3%, but both remain well above their IPO prices. 

Alexion Pharmaceuticals (NASDAQ:ALXN) stock rose 30% as the life sciences company agreed to be bought by U.K.-based AstraZeneca (NASDAQ:AZN) for $39 billion, the biggest deal in biotech M&A this year. AstraZeneca ADRs fell some 6.4%, amid concern that is overpaying, and awareness that Astra will be paying some two-thirds of the acquisition price in stock.

Elsewhere, trading in SolarWinds (NYSE:SWI) stock was briefly suspended after it fell sharply in response to reports that many of its tools had been compromised in what appeared to be a Russian-sponsored attack on U.S. government agencies. The stock resumed trading down 13.8% from Friday's close.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.